| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Diversion | 21 | 2017 | 43 | 2.740 |
Why?
|
| Urinary Reservoirs, Continent | 13 | 2012 | 24 | 2.550 |
Why?
|
| Penile Neoplasms | 13 | 2019 | 33 | 2.000 |
Why?
|
| Organ Sparing Treatments | 5 | 2019 | 36 | 1.570 |
Why?
|
| Adrenal Gland Neoplasms | 8 | 2019 | 67 | 1.370 |
Why?
|
| Kidney Neoplasms | 15 | 2019 | 433 | 1.340 |
Why?
|
| Adrenalectomy | 3 | 2019 | 37 | 1.200 |
Why?
|
| Penis | 14 | 2017 | 98 | 1.070 |
Why?
|
| Pheochromocytoma | 6 | 2008 | 34 | 0.960 |
Why?
|
| Urologic Surgical Procedures, Male | 5 | 2019 | 37 | 0.910 |
Why?
|
| Urinary Incontinence | 4 | 2011 | 70 | 0.760 |
Why?
|
| Urinary Bladder Diseases | 5 | 2017 | 35 | 0.740 |
Why?
|
| Urethra | 24 | 2006 | 84 | 0.720 |
Why?
|
| Urinary Bladder | 24 | 2017 | 245 | 0.710 |
Why?
|
| Nephrectomy | 10 | 2019 | 178 | 0.690 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2017 | 238 | 0.680 |
Why?
|
| Adrenal Glands | 2 | 2019 | 43 | 0.670 |
Why?
|
| Testicular Neoplasms | 3 | 2019 | 132 | 0.620 |
Why?
|
| Prostatic Neoplasms | 10 | 2019 | 1548 | 0.610 |
Why?
|
| Ileum | 14 | 2011 | 132 | 0.570 |
Why?
|
| Ureteral Obstruction | 11 | 2013 | 105 | 0.540 |
Why?
|
| Urinary Fistula | 5 | 2012 | 20 | 0.520 |
Why?
|
| Adrenal Gland Diseases | 1 | 2016 | 13 | 0.520 |
Why?
|
| Urinary Bladder Neoplasms | 9 | 2019 | 557 | 0.510 |
Why?
|
| Printing, Three-Dimensional | 1 | 2016 | 69 | 0.480 |
Why?
|
| Vesico-Ureteral Reflux | 5 | 2011 | 81 | 0.450 |
Why?
|
| Humans | 153 | 2019 | 124703 | 0.440 |
Why?
|
| Male | 114 | 2019 | 61264 | 0.420 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2013 | 19 | 0.420 |
Why?
|
| Pelvic Neoplasms | 1 | 2013 | 21 | 0.420 |
Why?
|
| Vaginal Fistula | 1 | 2012 | 3 | 0.410 |
Why?
|
| Urology | 3 | 2017 | 75 | 0.400 |
Why?
|
| Vagina | 2 | 2012 | 194 | 0.390 |
Why?
|
| Dextrans | 1 | 2011 | 45 | 0.370 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2005 | 256 | 0.360 |
Why?
|
| Medical Illustration | 1 | 2011 | 18 | 0.360 |
Why?
|
| Biocompatible Materials | 1 | 2011 | 118 | 0.350 |
Why?
|
| Hyaluronic Acid | 1 | 2011 | 95 | 0.350 |
Why?
|
| Urinary Bladder, Neurogenic | 3 | 2010 | 46 | 0.340 |
Why?
|
| Surgical Flaps | 5 | 2010 | 204 | 0.340 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2010 | 28 | 0.330 |
Why?
|
| Scrotum | 3 | 2007 | 24 | 0.320 |
Why?
|
| Urologic Surgical Procedures | 5 | 2011 | 58 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 2092 | 0.300 |
Why?
|
| Prostatectomy | 9 | 2019 | 344 | 0.300 |
Why?
|
| Appendix | 4 | 2011 | 15 | 0.290 |
Why?
|
| Urodynamics | 3 | 2011 | 40 | 0.290 |
Why?
|
| Mesentery | 1 | 2007 | 28 | 0.280 |
Why?
|
| Ileostomy | 1 | 2007 | 31 | 0.280 |
Why?
|
| Colon, Transverse | 1 | 2007 | 6 | 0.270 |
Why?
|
| Counseling | 1 | 2008 | 217 | 0.270 |
Why?
|
| Follow-Up Studies | 17 | 2008 | 5160 | 0.250 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2006 | 668 | 0.250 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 441 | 0.240 |
Why?
|
| Quality of Life | 2 | 2017 | 1935 | 0.240 |
Why?
|
| Middle Aged | 52 | 2019 | 26796 | 0.230 |
Why?
|
| Hemangioma | 3 | 1994 | 94 | 0.230 |
Why?
|
| Ureteral Neoplasms | 3 | 2019 | 25 | 0.230 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2019 | 201 | 0.220 |
Why?
|
| Urinary Tract | 6 | 1979 | 60 | 0.220 |
Why?
|
| Adult | 51 | 2012 | 29481 | 0.220 |
Why?
|
| Stomach | 3 | 2004 | 272 | 0.210 |
Why?
|
| Omentum | 3 | 1992 | 47 | 0.210 |
Why?
|
| Vena Cava, Inferior | 3 | 2003 | 103 | 0.210 |
Why?
|
| Treatment Outcome | 14 | 2019 | 12354 | 0.210 |
Why?
|
| Androgens | 1 | 2005 | 274 | 0.210 |
Why?
|
| Vascular Neoplasms | 1 | 2003 | 32 | 0.200 |
Why?
|
| Circumcision, Male | 3 | 2006 | 25 | 0.200 |
Why?
|
| Muscle, Smooth | 9 | 1980 | 135 | 0.190 |
Why?
|
| Urethral Stricture | 7 | 1986 | 13 | 0.190 |
Why?
|
| Urinary Tract Infections | 2 | 2005 | 302 | 0.190 |
Why?
|
| Female | 52 | 2013 | 66557 | 0.190 |
Why?
|
| Pain | 2 | 2004 | 461 | 0.180 |
Why?
|
| Perineum | 6 | 2010 | 48 | 0.180 |
Why?
|
| Abnormalities, Multiple | 1 | 2007 | 960 | 0.180 |
Why?
|
| Colon | 4 | 2007 | 349 | 0.170 |
Why?
|
| Estramustine | 1 | 2000 | 4 | 0.170 |
Why?
|
| Aged | 30 | 2019 | 19763 | 0.170 |
Why?
|
| Urethral Neoplasms | 3 | 1994 | 9 | 0.170 |
Why?
|
| Endoscopy | 5 | 1994 | 280 | 0.160 |
Why?
|
| Life Expectancy | 1 | 2019 | 53 | 0.160 |
Why?
|
| Prostate-Specific Antigen | 1 | 2000 | 256 | 0.150 |
Why?
|
| Ablation Techniques | 1 | 2019 | 31 | 0.150 |
Why?
|
| Vesicovaginal Fistula | 2 | 1992 | 10 | 0.150 |
Why?
|
| Intraoperative Care | 1 | 1998 | 106 | 0.150 |
Why?
|
| Surgical Stomas | 1 | 1998 | 10 | 0.150 |
Why?
|
| Umbilicus | 1 | 1998 | 13 | 0.150 |
Why?
|
| Urinary Catheterization | 9 | 2007 | 81 | 0.150 |
Why?
|
| Adenocarcinoma | 7 | 1995 | 1023 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 3 | 2006 | 617 | 0.150 |
Why?
|
| Ureteroscopy | 2 | 2008 | 17 | 0.150 |
Why?
|
| Lithotripsy, Laser | 2 | 2008 | 12 | 0.140 |
Why?
|
| Kidney | 6 | 2019 | 1358 | 0.140 |
Why?
|
| Kidney Calculi | 6 | 1986 | 42 | 0.140 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2019 | 198 | 0.140 |
Why?
|
| Empyema | 1 | 2017 | 24 | 0.140 |
Why?
|
| Lipoma | 2 | 1993 | 24 | 0.140 |
Why?
|
| Ureter | 8 | 1993 | 97 | 0.130 |
Why?
|
| Dermatologic Surgical Procedures | 2 | 2007 | 45 | 0.130 |
Why?
|
| Child | 19 | 2010 | 24371 | 0.130 |
Why?
|
| Pelvis | 2 | 1995 | 71 | 0.130 |
Why?
|
| Malacoplakia | 1 | 1995 | 3 | 0.120 |
Why?
|
| SEER Program | 2 | 2019 | 202 | 0.120 |
Why?
|
| Colon, Sigmoid | 1 | 1995 | 13 | 0.120 |
Why?
|
| Ureterostomy | 1 | 1995 | 6 | 0.120 |
Why?
|
| Diethylstilbestrol | 1 | 1995 | 142 | 0.120 |
Why?
|
| Cystectomy | 2 | 2017 | 160 | 0.120 |
Why?
|
| Methods | 13 | 1988 | 149 | 0.120 |
Why?
|
| Kidney Diseases | 5 | 2007 | 481 | 0.120 |
Why?
|
| Radiography | 17 | 1993 | 821 | 0.120 |
Why?
|
| Combined Modality Therapy | 3 | 2008 | 1233 | 0.120 |
Why?
|
| Aged, 80 and over | 8 | 2017 | 6548 | 0.110 |
Why?
|
| Adolescent | 17 | 2008 | 19278 | 0.110 |
Why?
|
| Sclerotherapy | 1 | 1994 | 40 | 0.110 |
Why?
|
| Urinary Bladder Fistula | 2 | 2010 | 4 | 0.110 |
Why?
|
| Retrospective Studies | 10 | 2017 | 16325 | 0.110 |
Why?
|
| Biopsy, Needle | 2 | 2008 | 231 | 0.100 |
Why?
|
| Urologic Neoplasms | 1 | 1993 | 42 | 0.100 |
Why?
|
| Postoperative Care | 2 | 2011 | 298 | 0.100 |
Why?
|
| Spermatic Cord | 3 | 1977 | 12 | 0.100 |
Why?
|
| Urogenital Neoplasms | 1 | 2012 | 15 | 0.100 |
Why?
|
| Tuberous Sclerosis | 2 | 2008 | 120 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2017 | 1140 | 0.100 |
Why?
|
| Mortality, Premature | 1 | 2012 | 12 | 0.100 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1993 | 163 | 0.090 |
Why?
|
| Rheology | 1 | 2011 | 32 | 0.090 |
Why?
|
| Urination | 3 | 1980 | 23 | 0.090 |
Why?
|
| Calculi | 2 | 1983 | 15 | 0.090 |
Why?
|
| Ureteral Calculi | 3 | 2008 | 15 | 0.090 |
Why?
|
| Puberty | 1 | 2011 | 94 | 0.090 |
Why?
|
| Radiation Injuries | 1 | 1992 | 142 | 0.090 |
Why?
|
| Kidney Pelvis | 6 | 1975 | 44 | 0.090 |
Why?
|
| Phenoxybenzamine | 3 | 2008 | 12 | 0.090 |
Why?
|
| Survival Rate | 2 | 2008 | 2045 | 0.090 |
Why?
|
| Time Factors | 5 | 2010 | 6308 | 0.090 |
Why?
|
| Diverticulum | 3 | 1982 | 28 | 0.090 |
Why?
|
| Rectus Abdominis | 1 | 2010 | 8 | 0.080 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 1251 | 0.080 |
Why?
|
| Tissue Donors | 1 | 1993 | 494 | 0.080 |
Why?
|
| Postoperative Complications | 8 | 2004 | 3071 | 0.080 |
Why?
|
| Calcinosis | 3 | 2001 | 176 | 0.080 |
Why?
|
| Prostheses and Implants | 2 | 1988 | 152 | 0.080 |
Why?
|
| Angiomyolipoma | 1 | 2008 | 3 | 0.080 |
Why?
|
| Lasers, Solid-State | 1 | 2008 | 17 | 0.070 |
Why?
|
| Muscle Contraction | 5 | 1980 | 188 | 0.070 |
Why?
|
| Sickness Impact Profile | 1 | 2008 | 36 | 0.070 |
Why?
|
| Child, Preschool | 14 | 2008 | 14013 | 0.070 |
Why?
|
| Prostate | 5 | 1977 | 435 | 0.070 |
Why?
|
| Urography | 10 | 1978 | 31 | 0.070 |
Why?
|
| Parasympathomimetics | 4 | 1980 | 7 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 1993 | 643 | 0.070 |
Why?
|
| Castration | 2 | 2005 | 33 | 0.070 |
Why?
|
| Ejaculation | 1 | 2007 | 20 | 0.070 |
Why?
|
| Tramadol | 1 | 2007 | 10 | 0.070 |
Why?
|
| Serotonin Agents | 1 | 2007 | 14 | 0.070 |
Why?
|
| Coitus | 1 | 2007 | 20 | 0.070 |
Why?
|
| Neurosurgery | 1 | 2008 | 74 | 0.070 |
Why?
|
| Cystoscopy | 2 | 2005 | 44 | 0.070 |
Why?
|
| Sus scrofa | 1 | 2007 | 125 | 0.070 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 1987 | 30 | 0.070 |
Why?
|
| Genitalia, Female | 1 | 1987 | 47 | 0.070 |
Why?
|
| Hernia | 1 | 1986 | 19 | 0.070 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2007 | 79 | 0.060 |
Why?
|
| Ureteral Diseases | 2 | 1991 | 5 | 0.060 |
Why?
|
| Urethral Diseases | 2 | 1983 | 17 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2005 | 54 | 0.060 |
Why?
|
| Penile Diseases | 2 | 1975 | 11 | 0.060 |
Why?
|
| Surgery, Plastic | 1 | 1987 | 111 | 0.060 |
Why?
|
| Lymph Node Excision | 4 | 1994 | 164 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 185 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2006 | 244 | 0.060 |
Why?
|
| Cystitis, Interstitial | 1 | 2004 | 2 | 0.060 |
Why?
|
| Condylomata Acuminata | 2 | 1974 | 15 | 0.060 |
Why?
|
| Granuloma | 2 | 1976 | 68 | 0.060 |
Why?
|
| Carcinoma | 2 | 1977 | 286 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1690 | 0.060 |
Why?
|
| Sex Factors | 1 | 2008 | 1286 | 0.060 |
Why?
|
| Urination Disorders | 4 | 1979 | 18 | 0.060 |
Why?
|
| Cystitis | 1 | 2004 | 50 | 0.060 |
Why?
|
| Sympathomimetics | 2 | 1980 | 12 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 341 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 475 | 0.050 |
Why?
|
| Urinary Bladder Neck Obstruction | 3 | 1978 | 29 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 1284 | 0.050 |
Why?
|
| Intestinal Obstruction | 1 | 2004 | 94 | 0.050 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2002 | 4 | 0.050 |
Why?
|
| Vaginal Diseases | 1 | 1983 | 17 | 0.050 |
Why?
|
| Intestinal Fistula | 2 | 1991 | 28 | 0.050 |
Why?
|
| Renal Veins | 2 | 2001 | 36 | 0.050 |
Why?
|
| Thrombectomy | 1 | 2003 | 107 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2008 | 4803 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 669 | 0.050 |
Why?
|
| Urethral Obstruction | 1 | 1982 | 56 | 0.050 |
Why?
|
| Suture Techniques | 3 | 2010 | 196 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2004 | 760 | 0.050 |
Why?
|
| Age Factors | 1 | 2008 | 2819 | 0.050 |
Why?
|
| Varicose Veins | 1 | 2001 | 29 | 0.050 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2001 | 71 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 1269 | 0.050 |
Why?
|
| Reoperation | 1 | 2004 | 833 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2005 | 717 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2003 | 183 | 0.040 |
Why?
|
| Short Bowel Syndrome | 1 | 2001 | 65 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 1988 | 808 | 0.040 |
Why?
|
| Wilms Tumor | 3 | 1995 | 113 | 0.040 |
Why?
|
| Acidosis | 1 | 2001 | 93 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2017 | 2428 | 0.040 |
Why?
|
| Congenital Abnormalities | 4 | 1975 | 254 | 0.040 |
Why?
|
| Retroperitoneal Space | 3 | 1994 | 19 | 0.040 |
Why?
|
| Testosterone | 1 | 2005 | 533 | 0.040 |
Why?
|
| Animals | 15 | 2007 | 34028 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2006 | 2814 | 0.040 |
Why?
|
| Pharmacology | 1 | 1979 | 10 | 0.040 |
Why?
|
| Adrenergic Agents | 1 | 1979 | 12 | 0.040 |
Why?
|
| Nephritis | 2 | 1976 | 20 | 0.040 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1979 | 48 | 0.040 |
Why?
|
| Central Nervous System Agents | 1 | 1979 | 14 | 0.040 |
Why?
|
| Pressure | 2 | 1998 | 128 | 0.040 |
Why?
|
| Prostatic Hyperplasia | 3 | 1979 | 117 | 0.040 |
Why?
|
| Hypertension | 1 | 2008 | 1323 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 1328 | 0.040 |
Why?
|
| Renal Insufficiency | 1 | 2001 | 236 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2008 | 3447 | 0.040 |
Why?
|
| Ganglionic Blockers | 1 | 1978 | 13 | 0.040 |
Why?
|
| Prostatic Diseases | 1 | 1978 | 15 | 0.040 |
Why?
|
| Ganglionic Stimulants | 1 | 1978 | 11 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2019 | 135 | 0.040 |
Why?
|
| Triamcinolone | 1 | 1978 | 14 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 274 | 0.040 |
Why?
|
| Mullerian Ducts | 1 | 1978 | 33 | 0.040 |
Why?
|
| Cysts | 1 | 1978 | 101 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1979 | 243 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2003 | 577 | 0.040 |
Why?
|
| Blastomycosis | 1 | 1977 | 6 | 0.030 |
Why?
|
| Anuria | 1 | 2017 | 13 | 0.030 |
Why?
|
| Prostatitis | 1 | 1977 | 13 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2017 | 44 | 0.030 |
Why?
|
| Muscles | 4 | 1979 | 289 | 0.030 |
Why?
|
| United States | 3 | 2019 | 10897 | 0.030 |
Why?
|
| Contracture | 1 | 1977 | 24 | 0.030 |
Why?
|
| Inguinal Canal | 1 | 1976 | 12 | 0.030 |
Why?
|
| Hypospadias | 2 | 1975 | 78 | 0.030 |
Why?
|
| Infant | 4 | 2006 | 12471 | 0.030 |
Why?
|
| Margins of Excision | 1 | 2017 | 53 | 0.030 |
Why?
|
| Vas Deferens | 1 | 1976 | 22 | 0.030 |
Why?
|
| Drainage | 2 | 1975 | 258 | 0.030 |
Why?
|
| Leiomyosarcoma | 1 | 1976 | 28 | 0.030 |
Why?
|
| Foreign Bodies | 1 | 1977 | 104 | 0.030 |
Why?
|
| Liposarcoma | 1 | 1976 | 22 | 0.030 |
Why?
|
| Muscle Relaxation | 3 | 1980 | 16 | 0.030 |
Why?
|
| Guinea Pigs | 3 | 1980 | 166 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 1976 | 45 | 0.030 |
Why?
|
| Heart Atria | 2 | 1978 | 316 | 0.030 |
Why?
|
| Pyelonephritis | 1 | 1976 | 26 | 0.030 |
Why?
|
| Ankylosis | 1 | 1975 | 1 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 1979 | 361 | 0.030 |
Why?
|
| Abdomen | 2 | 1986 | 127 | 0.030 |
Why?
|
| Myelolipoma | 1 | 1995 | 3 | 0.030 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 1995 | 8 | 0.030 |
Why?
|
| Hip Joint | 1 | 1975 | 37 | 0.030 |
Why?
|
| Hemorrhage | 2 | 1976 | 469 | 0.030 |
Why?
|
| Obstetric Labor Complications | 1 | 1976 | 93 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2007 | 8187 | 0.030 |
Why?
|
| Diverticulitis, Colonic | 1 | 1974 | 7 | 0.030 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1995 | 61 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 1037 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 1974 | 55 | 0.030 |
Why?
|
| Thorax | 1 | 1974 | 73 | 0.030 |
Why?
|
| Treatment Failure | 1 | 1995 | 337 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1435 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 1356 | 0.030 |
Why?
|
| Fluorouracil | 1 | 1974 | 127 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1976 | 215 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 1973 | 35 | 0.030 |
Why?
|
| Ostomy | 1 | 1993 | 11 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 1977 | 332 | 0.030 |
Why?
|
| Patient Selection | 1 | 2017 | 695 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 1975 | 260 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 1177 | 0.030 |
Why?
|
| Testis | 1 | 1974 | 407 | 0.020 |
Why?
|
| Erythroplasia | 1 | 1992 | 2 | 0.020 |
Why?
|
| Leukoplakia | 1 | 1992 | 3 | 0.020 |
Why?
|
| Thoracic Surgery | 1 | 1974 | 161 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1975 | 262 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 1992 | 71 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 1993 | 1883 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 1977 | 852 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 676 | 0.020 |
Why?
|
| Stents | 2 | 1993 | 890 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 1980 | 325 | 0.020 |
Why?
|
| Saudi Arabia | 2 | 1986 | 38 | 0.020 |
Why?
|
| Laparoscopy | 1 | 1994 | 495 | 0.020 |
Why?
|
| Parasympathetic Nervous System | 2 | 1980 | 15 | 0.020 |
Why?
|
| Parasympatholytics | 2 | 1979 | 8 | 0.020 |
Why?
|
| Receptors, Adrenergic | 2 | 1980 | 29 | 0.020 |
Why?
|
| Histamine | 2 | 1979 | 44 | 0.020 |
Why?
|
| Dogs | 3 | 1980 | 768 | 0.020 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2008 | 24 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2008 | 128 | 0.020 |
Why?
|
| Digitalis Glycosides | 2 | 1979 | 5 | 0.020 |
Why?
|
| Holmium | 1 | 2007 | 9 | 0.020 |
Why?
|
| Biopsy | 3 | 1976 | 1237 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 1979 | 968 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 1987 | 61 | 0.020 |
Why?
|
| Pubic Bone | 1 | 1986 | 2 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2007 | 237 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2006 | 46 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 313 | 0.020 |
Why?
|
| Calcium | 2 | 1985 | 1099 | 0.020 |
Why?
|
| Urinary Calculi | 1 | 1985 | 18 | 0.020 |
Why?
|
| Ligation | 2 | 1977 | 135 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 721 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 680 | 0.010 |
Why?
|
| Anthropometry | 1 | 2005 | 199 | 0.010 |
Why?
|
| Posture | 2 | 1975 | 154 | 0.010 |
Why?
|
| Lymphatic Metastasis | 2 | 1994 | 414 | 0.010 |
Why?
|
| Fistula | 2 | 1974 | 49 | 0.010 |
Why?
|
| Cats | 2 | 1980 | 118 | 0.010 |
Why?
|
| Isoproterenol | 2 | 1980 | 106 | 0.010 |
Why?
|
| Norepinephrine | 2 | 1980 | 175 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 2050 | 0.010 |
Why?
|
| Acetylcholine | 3 | 1977 | 83 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10284 | 0.010 |
Why?
|
| Rabbits | 2 | 1980 | 710 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1993 | 3556 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 3 | 1977 | 28 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1980 | 8 | 0.010 |
Why?
|
| Muscle Tonus | 1 | 1980 | 7 | 0.010 |
Why?
|
| Prostaglandins F | 1 | 1980 | 9 | 0.010 |
Why?
|
| Inflammation | 2 | 1978 | 1431 | 0.010 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 1979 | 6 | 0.010 |
Why?
|
| Prochlorperazine | 1 | 1979 | 3 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1979 | 43 | 0.010 |
Why?
|
| Histamine Antagonists | 1 | 1979 | 16 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 2001 | 168 | 0.010 |
Why?
|
| Meningomyelocele | 1 | 1983 | 251 | 0.010 |
Why?
|
| Angiomatosis | 1 | 1979 | 6 | 0.010 |
Why?
|
| Chlorpromazine | 1 | 1979 | 12 | 0.010 |
Why?
|
| Bretylium Compounds | 1 | 1979 | 1 | 0.010 |
Why?
|
| Guanethidine | 1 | 1979 | 2 | 0.010 |
Why?
|
| Methyldopa | 1 | 1979 | 4 | 0.010 |
Why?
|
| Phentolamine | 1 | 1979 | 20 | 0.010 |
Why?
|
| Dihydroergotamine | 1 | 1979 | 10 | 0.010 |
Why?
|
| von Hippel-Lindau Disease | 1 | 1979 | 20 | 0.010 |
Why?
|
| Meprobamate | 1 | 1979 | 1 | 0.010 |
Why?
|
| Paraldehyde | 1 | 1979 | 1 | 0.010 |
Why?
|
| Chloral Hydrate | 1 | 1979 | 2 | 0.010 |
Why?
|
| Phenothiazines | 1 | 1979 | 5 | 0.010 |
Why?
|
| Meperidine | 1 | 1979 | 8 | 0.010 |
Why?
|
| Reserpine | 1 | 1979 | 12 | 0.010 |
Why?
|
| Nortriptyline | 1 | 1979 | 6 | 0.010 |
Why?
|
| Strychnine | 1 | 1979 | 7 | 0.010 |
Why?
|
| Picrotoxin | 1 | 1979 | 14 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1980 | 305 | 0.010 |
Why?
|
| Amphetamines | 1 | 1979 | 10 | 0.010 |
Why?
|
| Imipramine | 1 | 1979 | 18 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 1979 | 67 | 0.010 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1979 | 25 | 0.010 |
Why?
|
| Sialic Acids | 1 | 1979 | 20 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1979 | 88 | 0.010 |
Why?
|
| Baclofen | 1 | 1979 | 39 | 0.010 |
Why?
|
| Phenytoin | 1 | 1979 | 64 | 0.010 |
Why?
|
| Ergotamine | 1 | 1978 | 1 | 0.010 |
Why?
|
| Flavoxate | 1 | 1978 | 1 | 0.010 |
Why?
|
| Propranolol | 1 | 1979 | 127 | 0.010 |
Why?
|
| Dicyclomine | 1 | 1978 | 3 | 0.010 |
Why?
|
| Levodopa | 1 | 1979 | 91 | 0.010 |
Why?
|
| Chylous Ascites | 1 | 1978 | 11 | 0.010 |
Why?
|
| Morphine | 1 | 1979 | 90 | 0.010 |
Why?
|
| Angiotensins | 1 | 1978 | 8 | 0.010 |
Why?
|
| Aminophylline | 1 | 1978 | 8 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 1893 | 0.010 |
Why?
|
| Barium | 1 | 1978 | 17 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 1979 | 98 | 0.010 |
Why?
|
| Bradykinin | 1 | 1978 | 59 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 1979 | 84 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1978 | 48 | 0.010 |
Why?
|
| Calcium Phosphates | 1 | 1978 | 8 | 0.010 |
Why?
|
| Anti-Anxiety Agents | 1 | 1979 | 74 | 0.010 |
Why?
|
| Emepronium | 1 | 1978 | 1 | 0.010 |
Why?
|
| Pentolinium Tartrate | 1 | 1978 | 1 | 0.010 |
Why?
|
| Chlorisondamine | 1 | 1978 | 6 | 0.010 |
Why?
|
| Hexamethonium Compounds | 1 | 1978 | 6 | 0.010 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1978 | 6 | 0.010 |
Why?
|
| Mecamylamine | 1 | 1978 | 10 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 1979 | 669 | 0.010 |
Why?
|
| Chlorides | 1 | 1978 | 106 | 0.010 |
Why?
|
| Anesthetics | 1 | 1979 | 79 | 0.010 |
Why?
|
| Oxytocin | 1 | 1978 | 68 | 0.010 |
Why?
|
| Glass | 1 | 1977 | 12 | 0.010 |
Why?
|
| Injections | 1 | 1978 | 154 | 0.010 |
Why?
|
| Action Potentials | 1 | 1980 | 500 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1978 | 154 | 0.010 |
Why?
|
| Adrenergic Fibers | 1 | 1977 | 4 | 0.010 |
Why?
|
| Hypogastric Plexus | 1 | 1977 | 7 | 0.010 |
Why?
|
| Renal Artery | 1 | 1977 | 75 | 0.010 |
Why?
|
| Neurons, Efferent | 1 | 1977 | 1 | 0.010 |
Why?
|
| Serotonin | 1 | 1978 | 219 | 0.010 |
Why?
|
| Ganglia, Autonomic | 1 | 1977 | 4 | 0.010 |
Why?
|
| Urinary Tract Physiological Phenomena | 1 | 1977 | 2 | 0.010 |
Why?
|
| Genital Diseases, Male | 1 | 1976 | 12 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1978 | 204 | 0.010 |
Why?
|
| Reflex | 1 | 1977 | 51 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 1977 | 50 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 3430 | 0.010 |
Why?
|
| Receptors, Cholinergic | 1 | 1977 | 84 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1977 | 63 | 0.010 |
Why?
|
| Neuromuscular Junction | 1 | 1977 | 90 | 0.010 |
Why?
|
| Ecchymosis | 1 | 1976 | 11 | 0.010 |
Why?
|
| Necrosis | 1 | 1976 | 208 | 0.010 |
Why?
|
| Rupture | 1 | 1976 | 33 | 0.010 |
Why?
|
| Torsion Abnormality | 1 | 1976 | 34 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1977 | 141 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 1978 | 350 | 0.010 |
Why?
|
| Epididymis | 1 | 1976 | 55 | 0.010 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1975 | 30 | 0.010 |
Why?
|
| Organ Size | 1 | 1976 | 425 | 0.010 |
Why?
|
| Needles | 1 | 1975 | 51 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1977 | 350 | 0.010 |
Why?
|
| Angiography | 1 | 1976 | 215 | 0.010 |
Why?
|
| Fasciotomy | 1 | 1975 | 27 | 0.010 |
Why?
|
| Blood Vessels | 1 | 1975 | 102 | 0.010 |
Why?
|
| Hamartoma | 1 | 1975 | 52 | 0.010 |
Why?
|
| Paraplegia | 1 | 1975 | 94 | 0.010 |
Why?
|
| Hemangioma, Cavernous | 1 | 1974 | 19 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1974 | 69 | 0.010 |
Why?
|
| Apatites | 1 | 1974 | 1 | 0.010 |
Why?
|
| Proteus Infections | 1 | 1974 | 7 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1974 | 60 | 0.010 |
Why?
|
| Endoscopes | 1 | 1974 | 20 | 0.010 |
Why?
|
| Mycobacterium bovis | 1 | 1974 | 30 | 0.010 |
Why?
|
| Oxalates | 1 | 1974 | 32 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1976 | 382 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1974 | 298 | 0.010 |
Why?
|
| Magnesium | 1 | 1974 | 121 | 0.010 |
Why?
|
| Diatrizoate | 1 | 1973 | 3 | 0.010 |
Why?
|
| Phosphates | 1 | 1974 | 113 | 0.010 |
Why?
|
| Rats | 1 | 1980 | 3675 | 0.010 |
Why?
|
| Dermatitis | 1 | 1973 | 26 | 0.010 |
Why?
|
| Cicatrix | 1 | 1974 | 123 | 0.010 |
Why?
|
| Dilatation | 1 | 1973 | 64 | 0.010 |
Why?
|
| Pregnancy | 2 | 1995 | 7173 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1975 | 184 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 1993 | 173 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1974 | 129 | 0.010 |
Why?
|
| Pedigree | 1 | 1976 | 1605 | 0.010 |
Why?
|
| Fever | 1 | 1973 | 296 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1985 | 6147 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1974 | 673 | 0.000 |
Why?
|
| Intellectual Disability | 1 | 1975 | 1056 | 0.000 |
Why?
|
| Length of Stay | 1 | 1973 | 1311 | 0.000 |
Why?
|
| Prognosis | 1 | 1995 | 4626 | 0.000 |
Why?
|
| Parathyroid Hormone | 1 | 1985 | 73 | 0.000 |
Why?
|
| Brain | 1 | 1977 | 2982 | 0.000 |
Why?
|
| Hospitalization | 1 | 1973 | 1779 | 0.000 |
Why?
|
| Cyclic AMP | 1 | 1985 | 246 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1985 | 432 | 0.000 |
Why?
|
| Creatinine | 1 | 1985 | 390 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1985 | 311 | 0.000 |
Why?
|
| Circadian Rhythm | 1 | 1985 | 270 | 0.000 |
Why?
|
| Metaraminol | 1 | 1978 | 1 | 0.000 |
Why?
|
| Ephedrine | 1 | 1978 | 5 | 0.000 |
Why?
|
| Phenylpropanolamine | 1 | 1978 | 4 | 0.000 |
Why?
|
| Phenylephrine | 1 | 1978 | 38 | 0.000 |
Why?
|
| Belladonna Alkaloids | 1 | 1977 | 1 | 0.000 |
Why?
|
| Benactyzine | 1 | 1977 | 1 | 0.000 |
Why?
|
| Propantheline | 1 | 1977 | 1 | 0.000 |
Why?
|
| Hemicholinium 3 | 1 | 1977 | 3 | 0.000 |
Why?
|
| Cyclohexanes | 1 | 1977 | 7 | 0.000 |
Why?
|
| Atropine | 1 | 1977 | 31 | 0.000 |
Why?
|
| Mandelic Acids | 1 | 1977 | 6 | 0.000 |
Why?
|
| Bethanechol Compounds | 1 | 1977 | 2 | 0.000 |
Why?
|
| Methacholine Compounds | 1 | 1977 | 2 | 0.000 |
Why?
|
| Physostigmine | 1 | 1977 | 9 | 0.000 |
Why?
|
| Muscarine | 1 | 1977 | 6 | 0.000 |
Why?
|
| Carbachol | 1 | 1977 | 18 | 0.000 |
Why?
|
| Pyridinium Compounds | 1 | 1977 | 20 | 0.000 |
Why?
|
| Neostigmine | 1 | 1977 | 6 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1978 | 254 | 0.000 |
Why?
|
| Epinephrine | 1 | 1978 | 179 | 0.000 |
Why?
|
| Connective Tissue | 1 | 1977 | 22 | 0.000 |
Why?
|
| Basement Membrane | 1 | 1977 | 48 | 0.000 |
Why?
|
| Dopamine | 1 | 1978 | 282 | 0.000 |
Why?
|
| Cholinesterase Inhibitors | 1 | 1977 | 100 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1977 | 290 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1975 | 65 | 0.000 |
Why?
|
| Haplorhini | 1 | 1975 | 123 | 0.000 |
Why?
|
| Macaca | 1 | 1975 | 61 | 0.000 |
Why?
|
| Protein Binding | 1 | 1979 | 1736 | 0.000 |
Why?
|